Dehydrozingerone protects temozolomide-induced cognitive impairment in normal and C6 glioma rats besides enhancing its anticancer potential

Considering the cognitive impairment induced by temozolomide (TMZ) in glioblastoma survivors, the present study was aimed to evaluate the protective effect of dehydrozingerone (DHZ) against TMZ-induced cognitive impairment (chemobrain) and C6 cell line-induced glioma in male Wistar rats. In both che...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:3 Biotech
Main Authors: Pathak, Nandini, Cheruku, Sri Pragnya, Rao, Vanishree, Vibhavari, R. J. A., Sumalatha, Suhani, Gourishetti, Karthik, Rao, C. Mallikarjuna, Kumar, Nitesh
Formato: Artigo
Idioma:Inglês
Publicado: Springer International Publishing 2020
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7498526/
https://ncbi.nlm.nih.gov/pubmed/32995109
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13205-020-02427-7
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares